For the First Time TASE Announces a Dividend Distribution of NIS 8.77 Million (NIS 0.0877 per share) Tel Aviv Stock Exchange Ltd (TASE:TASE) today announced its financial results for the year ended December 31, 2019. For the First Time TASE Announces a Dividend Distribution of NIS 8.77 Million (NIS 0.0877 per share) to Its Shareholders. To view summary of the reports … [Read more...] about The Tel-Aviv Stock Exchange Ltd Reported Fourth Quarter and Year 2019 Results
Leading Israeli Hospitals Launch CLEW AI-based TeleICU to Support COVID-19 Crisis
NETANYA, Israel, March 24, 2020 - CLEW today announced that its TeleICU solution – CLEW-ICU – is being deployed by Tel Aviv Sourasky Medical Center (Ichilov Hospital) and Sheba Medical Center as an innovative new way to manage and treat patients infected with the COVID-19 virus while protecting frontline care workers. In anticipation of a surge in ICU admissions, both … [Read more...] about Leading Israeli Hospitals Launch CLEW AI-based TeleICU to Support COVID-19 Crisis
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide
Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J. - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the U.S. to … [Read more...] about Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide
Kitov Closes $6.0 Million Public Offering
TEL-AVIV, March 17, 2020 -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced the closing of its previously announced public offering of 20,000,000 units at a price to the public of $0.30 per unit, for gross proceeds of $6.0 million, before deducting … [Read more...] about Kitov Closes $6.0 Million Public Offering
Israeli Ministry of Health Clears a Path to Allow Per Patient Compassionate Use Treatment of Covid-19 Patients with Pluristem’s PLX Cells
HAIFA, Israel, March 17, 2020 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological products, today announced that the Israeli Ministry of Health has approved Pluristem’s request to seek approvals to treat COVID-19 coronavirus patients under the per-patient compassionate use framework in … [Read more...] about Israeli Ministry of Health Clears a Path to Allow Per Patient Compassionate Use Treatment of Covid-19 Patients with Pluristem’s PLX Cells